Doç. Dr. Nagehan Didem SARI

1. Clinical epidemiology and risk factors of herpes zoster in Türkiye: a decade-long, multicenter retrospective cohort study

ALIRAVCI I. D., TOSUN S., SARI N. D., Berk Cam H., Bayhan E., CERAN N., et al.

BMC Infectious Diseases , cilt.26, sa.1, 2026 (SCI-Expanded, Scopus)

2. Self-Reported History of Herpes Zoster and Awareness of Zoster Vaccination Among Healthcare Workers: A Multicenter Cross-Sectional Study

Ergün U., TOSUN S., Seremet Keskin A., DEMİRAY GÜRBÜZ E., Çiftci İ., Ayaz S., et al.

Vaccines , cilt.14, sa.8, 2026 (SCI-Expanded, Scopus)

3. Epidemiological profile and clinical outcomes of patients with mucormycosis: the multicenter retromucor study from Türkiye (2004–2024)

Çiçek Y., DUMLU R., KOÇAK M., Pirdal B. Z., Çelik M., SALTOĞLU N., et al.

European Journal of Clinical Microbiology and Infectious Diseases , cilt.45, sa.2, ss.537-555, 2026 (SCI-Expanded, Scopus)

4. Real-Life Experience of Hepatitis C Treatment with Direct-Acting Antivirals in Genotypes 2 and 3

Kaya S. Y., Kurtaran B., Çuvalcı N. Ö., ÖNLEN Y., Ceylan M. R., Zerdali E., et al.

Turkish Journal of Gastroenterology , cilt.37, sa.1, ss.113-120, 2026 (SCI-Expanded, Scopus, TRDizin)

5. Efficacy and Safety of Direct-Acting Antivirals in Patients with Hepatitis C Infection: Nationwide Real-life Data from Türkiye

Gunduz A., ÖZTOPRAK ÇUVALCI N., SARI N. D., Kurtaran B., ÖNLEN Y., Senates E., et al.

Turkish Journal of Gastroenterology , cilt.37, sa.6, ss.673-681, 2026 (SCI-Expanded, Scopus, TRDizin)

6. Epidemiological and clinical analysis, and outcomes of tuberculosis co-infection among people living with HIV in Türkiye (2014–2024) ClinSurv HIV cohort: A large case series

MERT A., Derin O., Zerdali E., Kaya A., Gül Ö., Borcak D., et al.

PLOS ONE , cilt.20, sa.8 August, 2025 (SCI-Expanded, Scopus)

7. Assisting the Diagnosis of Cirrhosis in Chronic Hepatitis C Patients Based on Machine Learning Algorithms: A Novel Non-Invasive Approach

DİRİCAN E., Bal T., Onlen Y., Sarigul F., User U., SARI N. D., et al.

Journal of Clinical Laboratory Analysis , cilt.39, sa.12, 2025 (SCI-Expanded, Scopus)

8. Malaria in Turkey: A comprehensive analysis of diagnosis, treatment, and the impact of COVID-19, ten years after malaria elimination (2012–2023)

Şahin Ö. E., Kalay Z., SARI N. D., BATIREL A., Ersöz G., TUNCER ERTEM G., et al.

Travel Medicine and Infectious Disease , cilt.64, 2025 (SCI-Expanded, Scopus)

9. Treatment initiation rates of patients with positive anti-hepatitis C virus results in tertiary hospitals in Turkey

Çelen M. K., Şengel B. E., KAYA Ş., Demirtürk N., AZAP A., Pullukçu H., et al.

Journal of Infection in Developing Countries , cilt.18, sa.3, ss.441-449, 2024 (SCI-Expanded, Scopus)

10. Evaluation of the implementation of WHO infection prevention and control core components in Turkish health care facilities: results from a WHO infection prevention and control assessment framework (IPCAF)—based survey

Azak E., SERTÇELİK A., Ersoz G., Celebi G., ESER F., BATIREL A., et al.

Antimicrobial Resistance and Infection Control , cilt.12, sa.1, 2023 (SCI-Expanded, Scopus)

11. Fat Necrosis of the Breast Mimicking Breast Cancer in a Male Patient following Wax Hair Removal

Karaali M. G., SARI N. D., Altunkaynak M., Sarı Y., LEBLEBİCİ C., Aksu A. E. K.

Cutis , cilt.111, sa.3, 2023 (SCI-Expanded, Scopus)

12. Enigma of COVID-19: is “multisystem inflammatory syndrome in adults” (MIS-A) predictable?

Serin I., SARI N. D., Gunaltili M., Karakilic A., Gulesir B., Kal Kolik B., et al.

BMC Infectious Diseases , cilt.22, sa.1, 2022 (SCI-Expanded, Scopus)

13. In a Real-Life Setting, Direct-Acting Antivirals to People Who Inject Drugs with Chronic Hepatitis C in Turkey

Yildirim F. S., User U., SARI N. D., Kurtaran B., Önlen Y., Senates E., et al.

Turkish Journal of Gastroenterology , cilt.33, sa.11, ss.971-978, 2022 (SCI-Expanded, Scopus, TRDizin)

14. Efficacy and Safety of Direct-Acting Antivirals in Elderly Patients with Chronic Hepatitis C: A Nationwide Real-Life, Observational, Multicenter Study from Turkey

ÖNLEN Y., Bal T., ÇABALAK M., ÖZTOPRAK ÇUVALCI N., SARI N. D., Kurtaran B., et al.

Turkish Journal of Gastroenterology , cilt.33, sa.10, ss.862-873, 2022 (SCI-Expanded, Scopus, TRDizin)

15. Could serum thrombocyte/lymphocyte (TLR), neutrophil/lymphocyte (NLR) and neutro-phil/albumin (NAR) ratios be indicators of hospitalization and mortality in COVID-19?

SARI N. D., Serin I., BAKIR A., ALAÇAM S.

Iranian Journal of Microbiology , cilt.14, sa.6, ss.913-920, 2022 (ESCI, Scopus)

16. Evaluation of Intraventricular/Intrathecal Antimicrobial Therapy in the Treatment of Nosocomial Meningitis Caused by Multidrug-Resistant Gram-Negative Bacteria after Central Nervous System Surgery

SARI N. D., Baltali S., Serin I., Antar V.

Canadian Journal of Infectious Diseases and Medical Microbiology , cilt.2021, 2021 (SCI-Expanded, Scopus)

17. The evaluation of the factors affecting mortality in cases of hiv-infected pneumocystis jiroveci pneumonia Hiv infekte pneumocystis jiroveci pnömonisi (Pjp) olgularında mortaliteyi etkileyen faktörler

İNCİ A., Konyalı A. R., SARI N. D.

Klimik Dergisi , cilt.34, sa.2, ss.109-112, 2021 (ESCI, Scopus)

18. Could the ABO Blood Group Types be Associated with COVID-19 Mortality?

ALAÇAM S., SARI N. D.

Haseki Tip Bulteni , cilt.59, sa.4, ss.345-349, 2021 (ESCI, Scopus, TRDizin)

19. Clinical Profile and Predictors of Severe Malaria: A Study from Two Tertiary Care Centers in İstanbul Şiddetli Sıtmanın Klinik Profili ve Göstergeleri: İstanbul’da İki Üçüncü Basamak Hastaneden Çalışma

Korkusuz R., KARABELA Ş. N., SARI N. D., Şenoğlu S., Ünlü E. C., KART YAŞAR K.

Medical Journal of Bakirkoy , cilt.17, sa.3, ss.268-273, 2021 (ESCI, Scopus, TRDizin)

20. A new parameter in COVID-19 pandemic: initial lactate dehydrogenase (LDH)/Lymphocyte ratio for diagnosis and mortality

Serin I., SARI N. D., Dogu M. H., Acikel S. D., Babur G., Ulusoy A., et al.

Journal of Infection and Public Health , cilt.13, sa.11, ss.1664-1670, 2020 (SCI-Expanded, Scopus)